News

Best Life on MSN13h
Ozempic and Wegovy May Have Landed 25,000 People in the ER—Here's the Scary Reason Why
Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.
Medindia14h
FDA accepts filing application for oral semaglutide 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity
Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy® ...
Revealed: The VERY ordinary suburban home of the woman who invented Ozempic... and while she'll never move house - despite making her bosses £150billion
Lotte Bjerre Knudsen lives comfortably in this pleasant, but not showy, £900,000 apartment in central Copenhagen with her ...
Why Hims & Hers Health, Inc. (HIMS) Went Up On Friday
We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a ...
WHO backs use of weight-loss drugs for adults globally, raises cost issue
In 2023, experts decided against adding obesity drugs to the World Health Organisation's essential medicines list.